236 related articles for article (PubMed ID: 18075283)
1. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.
Micic D; Sumarac-Dumanovic M; Kendereski A; Cvijovic G; Zoric S; Pejkovic D; Micic J; Milic N; Dieguez C; Casanueva FF
J Endocrinol Invest; 2007 Nov; 30(10):820-7. PubMed ID: 18075283
[TBL] [Abstract][Full Text] [Related]
2. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
3. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
4. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
5. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
[TBL] [Abstract][Full Text] [Related]
6. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Lebkowska A; Milewski R; Górska M; Otziomek E; Nikolajuk A; Wolczynski S; Kowalska I
Endocr J; 2016 Dec; 63(12):1107-1112. PubMed ID: 27616010
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
[TBL] [Abstract][Full Text] [Related]
8. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
[TBL] [Abstract][Full Text] [Related]
9. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
10. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
11. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
Harrison CL; Stepto NK; Hutchison SK; Teede HJ
Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
[TBL] [Abstract][Full Text] [Related]
12. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.
Waśko R; Komarowska H; Warenik-Szymankiewicz A; Sowiński J
Horm Metab Res; 2004 Mar; 36(3):170-3. PubMed ID: 15057670
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.
Garin MC; Butts SF; Sarwer DB; Allison KC; Senapati S; Dokras A
Endocrine; 2017 Mar; 55(3):907-913. PubMed ID: 28004236
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and oxidative marker in women with PCOS.
Bannigida DM; Nayak BS; Vijayaraghavan R
Arch Physiol Biochem; 2020 May; 126(2):183-186. PubMed ID: 30450993
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
17. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
18. Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Endocr J; 2013; 60(9):1107-13. PubMed ID: 23801024
[TBL] [Abstract][Full Text] [Related]
19. Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome.
Panidis D; Macut D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Spanos N; Petakov M; Bjekic J; Damjanovic S
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):99-105. PubMed ID: 16460870
[TBL] [Abstract][Full Text] [Related]
20. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
